Reviva Pharmaceuticals Holdings, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €157.21M +78.4% €16.63M -191.9% 10.6% +0.31 pp N/A N/A
    (estimated) €88.13M +∞% -€18.11M -58.7% -20.5% -0.21 pp N/A N/A
    (estimated) €0.00 -100.0% -€43.82M +64.0% N/A N/A N/A
    (estimated) €4.26M +∞% -€26.72M +16.0% -626.6% -6.3 pp N/A N/A
    (estimated) €0.00 +NaN% -€23.03M -9.8% N/A N/A N/A
    €0.00 +NaN% -€25.52M -23.8% N/A -€28.61M +18.4% N/A
    €0.00 +NaN% -€33.49M +61.3% N/A -€24.16M +49.4% N/A
    €0.00 +NaN% -€20.76M +185.6% N/A -€16.17M +77.7% N/A
    €0.00 +NaN% -€7.27M +906.3% N/A -€9.10M +4,783.8% N/A
    €0.00 +NaN% -€722.31K -49.6% N/A -€186.32K -79.6% N/A
    €0.00 -€1.43M N/A -€913.82K N/A

    Notifications